2026, Número 1
Siguiente >>
Cardiovasc Metab Sci 2026; 37 (1)
El índice de triglicéridos y glucosa y su utilidad en la práctica clínica como herramienta de evaluación del riesgo cardiovascular
Martínez-Ruiz H, Nájera N, Ceballos G
Idioma: Inglés [English version]
Referencias bibliográficas: 7
Paginas: 5-6
Archivo PDF: 257.87 Kb.
RESUMEN
REFERENCIAS (EN ESTE ARTÍCULO)
DeFronzo RA FE. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991; 14 (3): 173-194.
Chen H, Sullivan G, Quon MJ. Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes. 2005; 54 (7): 1914-1925.
Li C, Qi Q, Li W, Zhang X, Li L, Deng J et al. Triglyceride-glucose index predicts major adverse cardiovascular and cerebrovascular events in non-diabetic individuals. Balkan Med J. 2025; 42 (4): 339-346.
Xu F, Feng Y, Zhong X. Higher triglyceride-glucose index is associated with increased risk of stroke among middle-aged and elderly Chinese: a national longitudinal study. Sci Rep. 2024; 14 (1): 19054.
Sánchez-Íñigo L, Navarro-González D, Fernández-Montero A, Pastrana-Delgado J, Martínez JA. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016; 46 (2): 189-197.
D'Elia L, Rendina D, Iacone R, Russo O, Strazzullo P, Galletti F. Triglyceride-glucose index, HOmeostatic Model Assessment index, and new-onset hypertension in middle-aged men. J Hypertens. 2026; 44 (1): 139-146.
Liu C, Liang D, Xiao K, Xie L. Association between the triglyceride–glucose index and all cause and CVD mortality in the young population with diabetes. Cardiovasc Diabetol. 2024; 23 (1): 171.